C23H23ClN6O2
450.9 g/mol
API
Nemorexant
CAS1505484-82-1
Category
API
Compound Class
Heterocycle
Primary Use
Pharmaceutical Raw Material
Nemorexant is a pharmaceutical raw material that functions as an orexin receptor antagonist, commonly used in the manufacturing of medications for insomnia. It is a research compound studied for its role in modulating wakefulness and sleep regulation.
pharmaceutical raw material for insomnia therapiesresearch compound for orexin receptor studies
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1505484-82-1
Related Compounds
StrongSame Parent
Daridorexant hydrochloride
CAS1792993-84-0
pharmaceutical raw material
ApplicationSame Use
Suvorexant
CAS1030377-33-3
pharmaceutical raw material
ReferenceSame Category
Tolvaptan
CAS150683-30-0
pharmaceutical raw material
ReferenceSame Category
Oxybutynin chloride
CAS1508-65-2
pharmaceutical raw material
ReferenceSame Category
Tropicamide
CAS1508-75-4
pharmaceutical raw material
ReferenceSame Category
Procyclidine hydrochloride
CAS1508-76-5
pharmaceutical raw material
Safety Reference
H413May cause long lasting harmful effects to aquatic life
Identifiers
IUPAC Name
[(2S)-2-(5-chloro-4-methyl-1H-benzimidazol-2-yl)-2-methylpyrrolidin-1-yl]-[5-methoxy-2-(triazol-2-yl)phenyl]methanone
InChIKey
NBGABHGMJVIVBW-QHCPKHFHSA-N
SMILES
CC1=C(C=CC2=C1N=C(N2)[C@@]3(CCCN3C(=O)C4=C(C=CC(=C4)OC)N5N=CC=N5)C)Cl
Synonyms (21)
- ACT 541468;ACT-541468
- DEA NO. 2410
- Daridorexant
- Daridorexant free base
- Nemorexant
- Nemorexant (DISCONTINUED)
- Quviviq
- US9732075, Example 5.36
- daridorexantum
- nemorexant (former name)